Cytokinetics CYTK Reimbursements — Revenue
Discontinued — last reported Q4 '20
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Cytokinetics’s 10-K, filed February 26, 2021, on SEC EDGAR. View the filing →
Questions, answered.
- What does reimbursements — revenue mean?
- Revenue earned by performing specific research or development services for a partner under a contractual agreement.
- How do you interpret reimbursements — revenue?
- An increase suggests successful execution of collaborative research programs or expanded partnership activity, while a decrease may indicate the completion of specific milestones or a shift in partnership strategy.
- How does reimbursements — revenue compare across companies?
- Comparable to 'Collaboration Revenue' or 'Contract Research Revenue' reported by other clinical-stage biopharmaceutical companies engaged in co-development or licensing agreements.